Misha Miroslav Backonja

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. ncbi request reprint Use of anticonvulsants for treatment of neuropathic pain
    Misha Miroslav Backonja
    Department of Neurology, University of Wisconsin Hospital and Clinics, Room H6 574, 600 Highland Avenue, Madison, WI 53792 5132, USA
    Neurology 59:S14-7. 2002
  2. doi request reprint Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus
    Miroslav Misha Backonja
    Department of Neurology, University of Wisconsin Madison, Madison, WI, USA
    Pain 154:1807-19. 2013
  3. doi request reprint Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities
    Miroslav Misha Backonja
    Department of Neurology, University of Wisconsin Madison, 600 Highland Avenue, Madison, WI 53792, USA
    Clin J Pain 25:641-7. 2009
  4. doi request reprint NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study
    Miroslav Backonja
    University of Wisconsin Madison, Madison, WI 53792, USA
    Lancet Neurol 7:1106-12. 2008
  5. ncbi request reprint Rational multidrug therapy in the treatment of neuropathic pain
    Misha Miroslav Backonja
    Department of Neurology, University of Wisconsin Madison, 53792, USA
    Curr Pain Headache Rep 10:34-8. 2006
  6. ncbi request reprint Neuropathic pain symptoms relative to overall pain rating
    Misha Miroslav Backonja
    Department of Neurology, University of Wisconsin Madison, Madison, Wisconsin 53792, USA
    J Pain 5:491-7. 2004
  7. ncbi request reprint Neuromodulating drugs for the symptomatic treatment of neuropathic pain
    Miroslav Backonja
    University of Wisconsin Hospital, Department of Neurology H6 570, 600 Highland Avenue, Madison, WI 53792, USA
    Curr Pain Headache Rep 8:212-6. 2004
  8. ncbi request reprint Neuropathic pain questionnaire--short form
    Misha Miroslav Backonja
    Department of Neurology, University of Wisconsin, Madison, Wisconsin 53792, USA
    Clin J Pain 19:315-6. 2003
  9. ncbi request reprint Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial
    M Backonja
    Department of Neurology, University of Wisconsin, Madison 53792, USA
    JAMA 280:1831-6. 1998
  10. ncbi request reprint Defining neuropathic pain
    Misha Miroslav Backonja
    Department of Neurology, University of Wisconsin Medical School, University of Wisconsin, Madison 53792, USA
    Anesth Analg 97:785-90. 2003

Detail Information

Publications31

  1. ncbi request reprint Use of anticonvulsants for treatment of neuropathic pain
    Misha Miroslav Backonja
    Department of Neurology, University of Wisconsin Hospital and Clinics, Room H6 574, 600 Highland Avenue, Madison, WI 53792 5132, USA
    Neurology 59:S14-7. 2002
    ..Evidence supporting the efficacy of anticonvulsants in treatment of such pain is evolving. Additional clinical trials should provide information that will better define their role in neuropathic pain...
  2. doi request reprint Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus
    Miroslav Misha Backonja
    Department of Neurology, University of Wisconsin Madison, Madison, WI, USA
    Pain 154:1807-19. 2013
    ..When appropriate standards, as discussed here, are applied, QST can provide important and unique information about the functional status of somatosensory system, which would be complementary to already existing clinical methods. ..
  3. doi request reprint Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities
    Miroslav Misha Backonja
    Department of Neurology, University of Wisconsin Madison, 600 Highland Avenue, Madison, WI 53792, USA
    Clin J Pain 25:641-7. 2009
    ..Together with the companion manuscript, this review provides definitions that should help further the use of QST as a diagnostic tool as well...
  4. doi request reprint NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study
    Miroslav Backonja
    University of Wisconsin Madison, Madison, WI 53792, USA
    Lancet Neurol 7:1106-12. 2008
    ..We report the results of a randomised, double blind, 12-week study of the efficacy and safety of one application of NGX-4010 in patients with PHN...
  5. ncbi request reprint Rational multidrug therapy in the treatment of neuropathic pain
    Misha Miroslav Backonja
    Department of Neurology, University of Wisconsin Madison, 53792, USA
    Curr Pain Headache Rep 10:34-8. 2006
    ..MDT for neuropathic pain is based on a comprehensive clinical neuropathic pain assessment and ongoing monitoring of the drug therapy's efficacy and adverse effects, administering one drug at the time...
  6. ncbi request reprint Neuropathic pain symptoms relative to overall pain rating
    Misha Miroslav Backonja
    Department of Neurology, University of Wisconsin Madison, Madison, Wisconsin 53792, USA
    J Pain 5:491-7. 2004
    ..Quantitative analysis, as performed in this study, is one of the steps in developing an approach for elucidating the relationship between neuropathic pain symptoms and underlying mechanisms...
  7. ncbi request reprint Neuromodulating drugs for the symptomatic treatment of neuropathic pain
    Miroslav Backonja
    University of Wisconsin Hospital, Department of Neurology H6 570, 600 Highland Avenue, Madison, WI 53792, USA
    Curr Pain Headache Rep 8:212-6. 2004
    ..A number of available anticonvulsants are undergoing clinical trials and many drugs with neuromodulatory properties are being considered for further development...
  8. ncbi request reprint Neuropathic pain questionnaire--short form
    Misha Miroslav Backonja
    Department of Neurology, University of Wisconsin, Madison, Wisconsin 53792, USA
    Clin J Pain 19:315-6. 2003
  9. ncbi request reprint Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial
    M Backonja
    Department of Neurology, University of Wisconsin, Madison 53792, USA
    JAMA 280:1831-6. 1998
    ..Pain is the most disturbing symptom of diabetic peripheral neuropathy. As many as 45% of patients with diabetes mellitus develop peripheral neuropathies...
  10. ncbi request reprint Defining neuropathic pain
    Misha Miroslav Backonja
    Department of Neurology, University of Wisconsin Medical School, University of Wisconsin, Madison 53792, USA
    Anesth Analg 97:785-90. 2003
    ....
  11. ncbi request reprint Anticonvulsants (antineuropathics) for neuropathic pain syndromes
    M M Backonja
    Department of Neurology, University of Wisconsin, Madison, USA
    Clin J Pain 16:S67-72. 2000
    ..More advances in our understanding of the mechanisms underlying neuropathic pain syndromes should further our opportunities to establish the role of anticonvulsants in the treatment of neuropathic pain...
  12. ncbi request reprint Anticonvulsants for the treatment of neuropathic pain syndromes
    Miroslav Backonja
    University of Wisconsin Hospital, Department of Neurology H6 570, 600 Highland Avenue, Madison, WI 53792, USA
    Curr Pain Headache Rep 7:39-42. 2003
    ..This article is an evidence-based summary of randomized clinical trials published in peer-reviewed journals regarding the efficacy of anticonvulsants for the treatment of neuropathic pain...
  13. ncbi request reprint Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials
    Miroslav Backonja
    Department of Neurology, Anesthesiology, and Rehabilitation Medicine, University of Wisconsin Hospital and Clinics, Madison, Wisconsin 53792, USA
    Clin Ther 25:81-104. 2003
    ..Tricyclic antidepressants are considered first-line agents for neuropathic pain, but their use is limited by unwanted side effects and a risk of cardiovascular mortality...
  14. ncbi request reprint Pain ratings at the thresholds are necessary for interpretation of quantitative sensory testing
    Kiesa Getz Kelly
    Department of Neurology, University of Wisconsin, 600 Highland Avenue, Madison, Wisconsin 53792, USA
    Muscle Nerve 32:179-84. 2005
    ..Suggestions are provided for combining threshold information for innocuous and noxious stimuli and related pain ratings for the evaluation of sensory nervous system function and, specifically, neuropathic pain...
  15. ncbi request reprint Development of a neuropathic pain questionnaire
    Steven J Krause
    Department of Orthopedics and Rehabilitation Medicine, University of Wisconsin, Madison, Wisconsin, USA
    Clin J Pain 19:306-14. 2003
    ..Consequently, it can be used for monitoring of neuropathic pain treatments and as an outcome measure...
  16. ncbi request reprint Pharmacologic management part 2: lesser-studied neuropathic pain diseases
    Misha Miroslav Backonja
    University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA
    Pain Med 5:S48-59. 2004
    ....
  17. ncbi request reprint Perceived controllability modulates the neural response to pain
    Tim V Salomons
    W M Keck Laboratory for Functional Brain Imaging and Behavior, University of Wisconsin Madison, Madison, Wisconsin 53706, USA
    J Neurosci 24:7199-203. 2004
    ....
  18. ncbi request reprint Pharmacologic management part 1: better-studied neuropathic pain diseases
    Misha Miroslav Backonja
    University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA
    Pain Med 5:S28-47. 2004
    ..Looking to the future, emerging therapies, such as pregabalin and newer N-methyl-D-aspartate-receptor blockers, may provide physicians and patients with new treatment options for more effective relief of pain...
  19. ncbi request reprint Individual differences in the effects of perceived controllability on pain perception: critical role of the prefrontal cortex
    Tim V Salomons
    University of Wisconsin Madison, WI, USA
    J Cogn Neurosci 19:993-1003. 2007
    ....
  20. doi request reprint NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension
    Misha Miroslav Backonja
    University of Wisconsin Madison, Madison, Wisconsin, USA
    Pain Med 11:600-8. 2010
    ..To assess the efficacy, tolerability, and safety of NGX-4010, a high-concentration capsaicin dermal patch (capsaicin 640 microg/cm(2), 8%) in patients with postherpetic neuralgia (PHN)...
  21. ncbi request reprint Mechanistic stratification of antineuralgic agents
    Ahmad Beydoun
    Department of Neurology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
    J Pain Symptom Manage 25:S18-30. 2003
    ....
  22. ncbi request reprint A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain
    Ivo W Tremont-Lukats
    Department of Neurology, University of Wisconsin Madison, Madison, WI 53792, USA
    Clin J Pain 22:266-71. 2006
    ..To determine the dose-response effect and safety of IV lidocaine at different dose infusion rates on spontaneous ongoing neuropathic pain...
  23. ncbi request reprint Classification of patients with pain based on neuropathic pain symptoms: comparison of an artificial neural network against an established scoring system
    Michael Behrman
    Department of Mathematics, University of Wisconsin Madison, Madison, WI, USA
    Eur J Pain 11:370-6. 2007
    ..Data analysis with ANNs provides a framework that extends what current approaches offer, especially for dynamic data, such as the rating of pain descriptors over time...
  24. pmc Voluntary facial displays of pain increase suffering in response to nociceptive stimulation
    Tim V Salomons
    Waisman Laboratory for Brain Imaging and Behavior, Waisman Center, Madison, Wisconsin 53705, USA
    J Pain 9:443-8. 2008
    ....
  25. ncbi request reprint Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain
    Charles E Argoff
    New York University School of Medicine and Cohn Pain Management Center, North Shore University Hospital, Manhasset, NY, USA
    Mayo Clin Proc 81:S12-25. 2006
    ..Ultimately, treatment choice must also Include consideration of adverse effects, individual patient factors such as comorbidities, and often cost...
  26. doi request reprint Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies
    Daniel K Kajdasz
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Clin Ther 29:2536-46. 2007
    ....
  27. ncbi request reprint Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    Clin J Pain 23:287-99. 2007
    ..To evaluate the outcomes associated with the use of controlled-release (CR) oxycodone for up to 3 years in the treatment of noncancer pain...
  28. ncbi request reprint Assessment: use of epidural steroid injections to treat radicular lumbosacral pain: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
    Carmel Armon
    Division of Neurology, Baystate Medical Center, Springfield, MA, USA
    Neurology 68:723-9. 2007
    ....
  29. ncbi request reprint New perspectives on the management of diabetic peripheral neuropathic pain
    Troels S Jensen
    Department of Endocrinology, Diabetology and Nutrition, Hôpital Jean Verdier APHP Paris Nord University, Bondy, France
    Diab Vasc Dis Res 3:108-19. 2006
    ..Irrespective of which treatment is offered, only about one third of patients are likely to achieve more than 50% pain relief. Further research to improve the diagnosis and management of DPNP is needed...
  30. ncbi request reprint Assessment: use of epidural steroid injections to treat radicular lumbosacral pain: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
    William M Landau
    Neurology 69:614; author reply 614-5. 2007
  31. ncbi request reprint Quantitative sensory testing for spinal cord stimulation in patients with chronic neuropathic pain
    Elon Eisenberg
    Pain Relief Unit, Rambam Medical Center, Haifa Pain Research Group, Technion Israel Institute of Technology, Haifa, Israel
    Pain Pract 6:161-5. 2006
    ..Participants: Thirteen patients with radicular leg pain due to failed back surgery syndrome (FBSS) or leg pain due to complex regional pain syndrome (CRPS) who were candidates for SCS...